Outpace Bio
Outpace Bio develops AI-powered protein design technologies to create engineered cell therapies for cancer treatment. Its platform programs cells to improve potency, specificity, persistence, and safety, aiming to make cell therapies effective, safe, and scalable across diverse cancer indications. The organization’s mission is to cure cancer by overcoming biological barriers through advanced cellular engineering.
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Biotechnology Research
- Founded
- 2020
- Type
- Corporation Seattle business license
- Employees
- 74
- Registered name
- Outpace Bio Inc Seattle business license
- Stage
- Series A
- Members see funding amounts. .
Is this your organization? Claim it
Founders
-
Marc Lajoie Executive Officer, Director, Promoter, Co-founder & Chief Executive Officer
-
Scott Boyken Executive Officer, Director, Promoter, Co-founder & Chief Innovation Officer
Executives
-
Aaron Foster Executive, Executive Officer, Chief Scientific Officer
-
Charity Scripture Executive, Executive Officer, Chief Development Officer
-
Eric Soller Executive, Executive Officer, Chief Business Officer